Atlas market file · Equity · United States
Cuprina Holdings (Cayman) LTDCUPR
- Last close
- 3.35
- Change
- -6.42%
- 96-bar range
- 1.76 – 14.8
- As of
- 6 Aug 2026
Cuprina Holdings (Cayman) LTD is an orthopedic, prosthetic & surgical appliances & supplies issuer listed as CUPR on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 71 weekly closes (-90.65% over the window).
Source rail: Yahoo Finance chart API (CUPR). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for CUPR. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
CUPR public profile
Orthopedic, prosthetic & surgical appliances & supplies issuer. Cuprina Holdings (Cayman) LTD is connected to current market context, cited company sources and its retained research file.
Cuprina Holdings (Cayman) LTD trades as CUPR on NASDAQ. Cuprina Holdings (Cayman) LTD (CUPR) has a latest verified close of 3.35, down 6.42%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files CUPR under USA Stocks for browsing.
What changed for Cuprina Holdings (Cayman) LTD today
Cuprina Holdings (Cayman) LTD (CUPR) closed the 2025 fiscal year with $38,789 in revenue but a staggering $3.6M net loss, raising questions about the sustainability of its niche medical product portfolio, including sterile blowfly larvae for chronic wound care and medical leech therapy (source: 20-F, period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1995704/000149315226031415/form20-fa.htm).
The company’s operations span Malaysia (where a key arrangement was terminated in July 2023) and the MENA region, where it plans to expand despite burning $7.1M in operating cash. With only $2.4M in cash reserves and liabilities of $2.7M, Cuprina’s financial footing resembles a patient on life support-technically alive but requiring constant intervention (source: 20-F, period ending 2025-12-31).
Recent filings reveal a 2026 Employee Incentive Plan approved by shareholders, alongside ongoing reliance on joint ventures and bank loans. The company’s diluted EPS of -$17.75 underscores the chasm between its growth rhetoric and fiscal reality. Meanwhile, a June 2026 press release touted regulatory clearance for unspecified products, though details remain scarce (source: 6-K 2026-06-15, https://www.sec.gov/Archives/edgar/data/1995704/000149315226028628/form6-k.htm).
Cuprina’s chart, if plotted, would resemble a rollercoaster with missing tracks: minimal liquidity, no clear profitability timeline, and heavy dependence on a single product category. The F-1 filing from July 2026 hints at potential capital raising, a move that could dilute existing shareholders already grappling with negative free cash flow (source: F-1 2026-07-07, https://www.sec.gov/Archives/edgar/data/1995704/000149315226032280/formf-1.htm).
Sources & evidence · 9 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
CUPR technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on CUPR
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep CUPR research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
CUPR FAQ
What is Cuprina Holdings (Cayman) LTD (CUPR)?Cuprina Holdings (Cayman) LTD (CUPR) has a latest verified close of 3.35, down 6.42%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
Cuprina Holdings (Cayman) LTD (CUPR) has a latest verified close of 3.35, down 6.42%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for CUPR?Cuprina Holdings (Cayman) LTD (CUPR) has a latest verified close of 3.35, down 6.42%, dated 6 Aug 2026. It brings the latest available chart, company context, cited...
Cuprina Holdings (Cayman) LTD (CUPR) has a latest verified close of 3.35, down 6.42%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files CUPR under USA Stocks for browsing.
How often is the CUPR page updated?The CUPR public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The CUPR public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for CUPR?The CUPR file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:CUPR. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The CUPR file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:CUPR. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on CUPR?Yes. The workstation can open CUPR, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open CUPR, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this CUPR page investment advice?No. The CUPR page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The CUPR page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
CUPR
Equity · evidence first